• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Oncology
    • View Item
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Oncology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Patterns and Outcomes of Subsequent Therapy After Immune Checkpoint Inhibitor Discontinuation in HCC

    Thumbnail
    View/ Open
    MuzaffarPatternsandOutcomesofSubsequentTherapyAfterImmuneCheckpointInhibitorDiscontinuation.pdf (580.5Kb)

    Show full item record
    Author
    Muzaffar, Mahvish; Bulumulle, Anushi; Sharma, Rohini
    URI
    http://hdl.handle.net/10342/11818
    Subject
     immune checkpoint inhibitors (ICIs); hepatocellular cancer (HCC); tyrosine kinase inhibitors (TKIs) 
    Date
    2022
    Citation:
    APA:
    Muzaffar, Mahvish, & Bulumulle, Anushi, & Sharma, Rohini. (January 2022). Patterns and Outcomes of Subsequent Therapy After Immune Checkpoint Inhibitor Discontinuation in HCC. , (), - . Retrieved from http://hdl.handle.net/10342/11818

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Muzaffar, Mahvish, and Bulumulle, Anushi, and Sharma, Rohini. "Patterns and Outcomes of Subsequent Therapy After Immune Checkpoint Inhibitor Discontinuation in HCC". . . (), January 2022. February 06, 2023. http://hdl.handle.net/10342/11818.
    Chicago:
    Muzaffar, Mahvish and Bulumulle, Anushi and Sharma, Rohini, "Patterns and Outcomes of Subsequent Therapy After Immune Checkpoint Inhibitor Discontinuation in HCC," , no. (January 2022), http://hdl.handle.net/10342/11818 (accessed February 06, 2023).
    AMA:
    Muzaffar, Mahvish, Bulumulle, Anushi, Sharma, Rohini. Patterns and Outcomes of Subsequent Therapy After Immune Checkpoint Inhibitor Discontinuation in HCC. . January 2022; (): . http://hdl.handle.net/10342/11818. Accessed February 06, 2023.
    Collections
    • Oncology

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback